Works matching IS 00070920 AND DT 2022 AND VI 126 AND IP 3

Results: 22
    1
    2

    Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 3, p. 440, doi. 10.1038/s41416-021-01624-2
    By:
    • Pietrasz, Daniel;
    • Wang-Renault, Shufang;
    • Taieb, Julien;
    • Dahan, Laetitia;
    • Postel, Mathilde;
    • Durand-Labrunie, Jerome;
    • Le Malicot, Karine;
    • Mulot, Claire;
    • Rinaldi, Yves;
    • Phelip, Jean-Marc;
    • Doat, Solene;
    • Blons, Hélène;
    • de Reynies, Aurelien;
    • Bachet, Jean-Baptiste;
    • Taly, Valérie;
    • Laurent-Puig, Pierre
    Publication type:
    Article
    3

    Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 3, p. 456, doi. 10.1038/s41416-021-01601-9
    By:
    • Suppan, Christoph;
    • Graf, Ricarda;
    • Jahn, Stephan;
    • Zhou, Qing;
    • Klocker, Eva Valentina;
    • Bartsch, Rupert;
    • Terbuch, Angelika;
    • Kashofer, Karl;
    • Regitnig, Peter;
    • Lindenmann, Joerg;
    • Posch, Florian;
    • Gerritsmann, Hanno;
    • Jost, Philipp J.;
    • Heitzer, Ellen;
    • Dandachi, Nadia;
    • Balic, Marija
    Publication type:
    Article
    4
    5
    6

    Cell-free DNA analysis in current cancer clinical trials: a review.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 3, p. 391, doi. 10.1038/s41416-021-01696-0
    By:
    • Cisneros-Villanueva, M.;
    • Hidalgo-Pérez, L.;
    • Rios-Romero, M.;
    • Cedro-Tanda, A.;
    • Ruiz-Villavicencio, C. A.;
    • Page, K.;
    • Hastings, R.;
    • Fernandez-Garcia, D.;
    • Allsopp, R.;
    • Fonseca-Montaño, M. A.;
    • Jimenez-Morales, S.;
    • Padilla-Palma, V.;
    • Shaw, J. A.;
    • Hidalgo-Miranda, A.
    Publication type:
    Article
    7
    8
    9
    10

    Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 3, p. 430, doi. 10.1038/s41416-021-01648-8
    By:
    • Shohdy, Kyrillus S.;
    • Villamar, Dario M.;
    • Cao, Yen;
    • Trieu, Janson;
    • Price, Kristin S.;
    • Nagy, Rebecca;
    • Tagawa, Scott T.;
    • Molina, Ana M.;
    • Sternberg, Cora N.;
    • Nanus, David M.;
    • Mosquera, Juan Miguel;
    • Elemento, Olivier;
    • Sonpavde, Guru P.;
    • Grivas, Petros;
    • Vogelzang, Nicholas J.;
    • Faltas, Bishoy Morris
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18

    Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 3, p. 482, doi. 10.1038/s41416-021-01538-z
    By:
    • Subhash, Vinod Vijay;
    • Huang, Libby;
    • Kamili, Alvin;
    • Wong, Marie;
    • Chen, Dan;
    • Venn, Nicola C.;
    • Atkinson, Caroline;
    • Mayoh, Chelsea;
    • Venkat, Pooja;
    • Tyrrell, Vanessa;
    • Marshall, Glenn M.;
    • Cowley, Mark J.;
    • Ekert, Paul G.;
    • Norris, Murray D.;
    • Haber, Michelle;
    • Henderson, Michelle J.;
    • Sutton, Rosemary;
    • Fletcher, Jamie I.;
    • Trahair, Toby N.
    Publication type:
    Article
    19

    NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 3, p. 514, doi. 10.1038/s41416-021-01536-1
    By:
    • Rolfo, Christian;
    • Drilon, Alexander;
    • Hong, David;
    • McCoach, Caroline;
    • Dowlati, Afshin;
    • Lin, Jessica J.;
    • Russo, Alessandro;
    • Schram, Alison M.;
    • Liu, Stephen V.;
    • Nieva, Jorge J.;
    • Nguyen, Timmy;
    • Eshaghian, Shahrooz;
    • Morse, Michael;
    • Gettinger, Scott;
    • Mobayed, Mohammad;
    • Goldberg, Sarah;
    • Araujo-Mino, Emilio;
    • Vidula, Neelima;
    • Bardia, Aditya;
    • Subramanian, Janakiraman
    Publication type:
    Article
    20
    21
    22

    Variant allele frequency in baseline circulating tumour DNA to measure tumour burden and to stratify outcomes in patients with RAS wild-type metastatic colorectal cancer: a translational objective of the Valentino study.

    Published in:
    British Journal of Cancer, 2022, v. 126, n. 3, p. 449, doi. 10.1038/s41416-021-01591-8
    By:
    • Manca, Paolo;
    • Corallo, Salvatore;
    • Lonardi, Sara;
    • Fucà, Giovanni;
    • Busico, Adele;
    • Leone, Alberto Giovanni;
    • Corti, Francesca;
    • Antoniotti, Carlotta;
    • Procaccio, Letizia;
    • Smiroldo, Valeria;
    • Ratti, Margherita;
    • Murialdo, Roberto;
    • Racca, Patrizia;
    • Pagani, Filippo;
    • Randon, Giovanni;
    • Martinetti, Antonia;
    • Sottotetti, Elisa;
    • Prisciandaro, Michele;
    • Ambrosini, Margherita;
    • Raimondi, Alessandra
    Publication type:
    Article